Literature DB >> 15373990

[Prognostic value of Charlson comorbidity index at 30 days and 1 year after acute myocardial infarction].

Julio E Núñez1, Eduardo Núñez, Lorenzo Fácila, Vicente Bertomeu, Angel Llàcer, Vicent Bodí, Juan Sanchis, Rafael Sanjuán, María L Blasco, Luciano Consuegra, Angel Martínez, Francisco J Chorro.   

Abstract

INTRODUCTION AND
OBJECTIVES: The Charlson comorbidity index (CCI), an indicator of comorbidity, has been used as an adjusting variable in multivariate models. Because of its prognostic value per se for cardiovascular complications after acute myocardial infarction (AMI), we sought to determine the predictive value of the CCI for all-cause mortality and recurrent AMI 30 days and 1 year after the index event. PATIENTS AND
METHOD: We analyzed 1035 consecutive patients admitted with the diagnosis of AMI (ST elevation=508 and non-ST elevation=527). The composite endpoint was determined after 30 days (13.9%) and 1 year (26.3%) of follow-up. The CCI was calculated on admission, and other variables with prognostic value were also recorded. CCI was stratified in 4 categories: 1: CCI=0 (control), 2: CCI=1, 3: CCI=2,4: CCI> or =3. Cox proportional risks analysis was used for the multivariate analysis, and the C-statistic was calculated to assess the discriminative power of the models.
RESULTS: Hazard ratios (95% CI) estimated for each category of CCI were: 2=1.69 (1.10-2.59), 3=1.78 (1.08-2.92) and 4=1.57 (0.87-2.83) at 30 days; 2=1.62 (1.18-2.23), 3=2.00 (1.39-2.89) and 4=2.24 (1.50-3.36) at 1 year. Comparisons with the C-statistic between the nested multivariate models (with and without CCI) yielded values of 0.765 vs 0.750 after 30 days, and 0.751 vs 0.735 after 1 year.
CONCLUSIONS: Our data indicate that CCI is an independent predictor of mortality or recurrent AMI 30 days and 1 year after the index AMI.

Entities:  

Mesh:

Year:  2004        PMID: 15373990

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  19 in total

1.  Protein Cytokines, Cytokine Gene Polymorphisms, and Potential Acute Coronary Syndrome Symptoms.

Authors:  Sahereh Mirzaei; Larisa Burke; Anne G Rosenfeld; Susan Dunn; Jennifer R Dungan; Katherine Maki; Holli A DeVon
Journal:  Biol Res Nurs       Date:  2019-06-25       Impact factor: 2.522

2.  Deriving comorbidities from medical records using natural language processing.

Authors:  Hojjat Salmasian; Daniel E Freedberg; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2013-10-31       Impact factor: 4.497

3.  Charlson comorbidity index as a predictor of in-hospital death in acute ischemic stroke among very old patients: a single-cohort perspective study.

Authors:  Lorenzo Falsetti; Giovanna Viticchi; Nicola Tarquinio; Mauro Silvestrini; William Capeci; Vania Catozzo; Agnese Fioranelli; Laura Buratti; Francesco Pellegrini
Journal:  Neurol Sci       Date:  2016-05-11       Impact factor: 3.307

4.  Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome.

Authors:  Juan Sanchis; Julio Núñez; Vicente Bodí; Eduardo Núñez; Ana García-Alvarez; Clara Bonanad; Ander Regueiro; Xavier Bosch; Magda Heras; Joan Sala; Oscar Bielsa; Angel Llácer
Journal:  Mayo Clin Proc       Date:  2011-02-23       Impact factor: 7.616

5.  The incidence of myocardial infarction after lumbar spine surgery.

Authors:  Brett Harwin; Blake Formanek; Mark Spoonamore; Djani Robertson; Zorica Buser; Jeffrey C Wang
Journal:  Eur Spine J       Date:  2019-07-19       Impact factor: 3.134

6.  Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.

Authors:  Kota Murohashi; Yu Hara; Yusuke Saigusa; Nobuaki Kobayashi; Takashi Sato; Masaki Yamamoto; Makoto Kudo; Takeshi Kaneko
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

7.  25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study.

Authors:  Morten Schmidt; Jacob Bonde Jacobsen; Timothy L Lash; Hans Erik Bøtker; Henrik Toft Sørensen
Journal:  BMJ       Date:  2012-01-25

8.  Hospital mortality in acute coronary syndrome: differences related to gender and use of percutaneous coronary procedures.

Authors:  María J Aguado-Romeo; Soledad Márquez-Calderón; María L Buzón-Barrera
Journal:  BMC Health Serv Res       Date:  2007-07-13       Impact factor: 2.655

9.  An analysis of real-world cost-effectiveness of TAVI in South Africa.

Authors:  Thomas A Mabin; Pascal Condolfi
Journal:  Cardiovasc J Afr       Date:  2014 Jan-Feb       Impact factor: 1.167

10.  Risk factors for death in septic shock: A retrospective cohort study comparing trauma and non-trauma patients.

Authors:  Sophie Medam; Laurent Zieleskiewicz; Gary Duclos; Karine Baumstarck; Anderson Loundou; Julie Alingrin; Emmanuelle Hammad; Coralie Vigne; François Antonini; Marc Leone
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.